Clorox (NYSE:CLX) Stock Rating Upgraded by TD Cowen

Clorox (NYSE:CLX) was upgraded by equities researchers at TD Cowen from a “sell” rating to a “hold” rating in a research report issued on Wednesday, FinViz reports. The brokerage currently has a $170.00 price target on the stock, up from their prior price target of $155.00. TD Cowen’s price objective would suggest a potential upside of 4.70% from the stock’s current price.

A number of other research analysts also recently issued reports on the stock. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Barclays increased their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. boosted their price objective on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $155.00.

Clorox Trading Down 0.1 %

Shares of NYSE CLX opened at $162.37 on Wednesday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock’s 50 day moving average price is $161.75 and its two-hundred day moving average price is $146.46. Clorox has a 52-week low of $125.46 and a 52-week high of $169.09. The stock has a market capitalization of $20.10 billion, a P/E ratio of 56.57, a PEG ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. The business’s quarterly revenue was up 27.0% on a year-over-year basis. On average, analysts anticipate that Clorox will post 6.81 earnings per share for the current fiscal year.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.57% of the company’s stock.

Institutional Trading of Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of CLX. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Clorox by 99.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,813 shares of the company’s stock valued at $7,136,000 after acquiring an additional 22,882 shares during the last quarter. Nordea Investment Management AB boosted its holdings in Clorox by 4.5% during the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock worth $1,519,000 after buying an additional 426 shares in the last quarter. Central Pacific Bank Trust Division acquired a new position in Clorox in the first quarter worth approximately $88,000. BI Asset Management Fondsmaeglerselskab A S lifted its position in shares of Clorox by 39.7% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 6,491 shares of the company’s stock valued at $994,000 after acquiring an additional 1,846 shares during the last quarter. Finally, SPC Financial Inc. boosted its stake in shares of Clorox by 3.0% during the 1st quarter. SPC Financial Inc. now owns 3,410 shares of the company’s stock worth $522,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.